BCR-ABL Tyrosine Kinase Inhibitors in Parkinson's Disease and Lewy Body Dementia: A Systematic Review

被引：0
|
作者：
Berton, Giovanni [1 ]
Lima, Amanda [2 ]
Borges, Rafael [3 ]
Cardoso, Nicole [4 ]
Marques, Marcos [5 ]
Oliveira, Thiago [6 ]
机构：
[1] Univ Passo Fundo, Sch Med, Passo Fundo, RS, Brazil
[2] Univ Positivo, Curitiba, Parana, Brazil
[3] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil
[4] Fac Santa Marcelina, Sao Paulo, Brazil
[5] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, Brazil
[6] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000204261
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P2-11.009
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Bcr-Abl tyrosine kinase inhibitors: a patent review
    Desogus, Andrea
    Schenone, Silvia
    Brullo, Chiara
    Tintori, Cristina
    Musumeci, Francesca
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2015, 25 (04) : 397 - 412
  • [2] Bcr-Abl tyrosine-kinase inhibitors (B-ATKI) and Parkinson's disease (PD)
    Shamim, E. A.
    Baker, S. F.
    Liu, F. F.
    Mane, K. K.
    Layug, J. G.
    Vupputuri, S.
    DiStasio, C. C.
    Khandhar, S. M.
    Neff, C.
    Van Den Eeden, S.
    Lungu, C.
    Cooley, R.
    Martel, H. S.
    Chen, C.
    Dorman, J.
    Sinkiewicz, M. A.
    Klingman, J.
    MOVEMENT DISORDERS, 2016, 31 : S257 - S257
  • [3] Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors
    Weatherald, Jason
    Bondeelle, Louise
    Chaumais, Marie-Camille
    Guignabert, Christophe
    Savale, Laurent
    Jais, Xavier
    Sitbon, Olivier
    Rousselot, Philippe
    Humbert, Marc
    Bergeron, Anne
    Montani, David
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (04)
  • [4] The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors
    Tetsuzo Tauchi
    Kazuma Ohyashiki
    International Journal of Hematology, 2006, 83 : 294 - 300
  • [5] The second generation of BCR-ABL tyrosine kinase inhibitors
    Tauchi, Tetsuzo
    Ohyashiki, Kazuma
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 83 (04) : 294 - 300
  • [6] Abelson Tyrosine Kinase Inhibitors in Parkinson's Disease and Lewy Body Dementia: A Systematic Review, Meta-analysis, and Meta-regression
    Gosch Berton, Giovanni
    Cyntia Lima Fonseca Rodrigues, Amanda
    dos Santos Borges, Rafael
    Rodrigues Cardoso, Nicole
    de Oliveira, Thiago Abrahao
    Oliveira Marques, Marcos Vinicius
    CLINICAL NEUROPHARMACOLOGY, 2024, 47 (04) : 113 - 119
  • [7] Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML
    Carofiglio, Francesca
    Lopalco, Antonio
    Lopedota, Angela
    Cutrignelli, Annalisa
    Nicolotti, Orazio
    Denora, Nunzio
    Stefanachi, Angela
    Leonetti, Francesco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 21
  • [8] DERMATOLOGIC ADVERSE EVENTS OF BCR-ABL TYROSINE KINASE INHIBITORS
    Shatokhina, E. A.
    Turkina, A. G.
    Kruglova, L. S.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2020, 65 (02): : 154 - 173
  • [9] BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia
    Schiffer, Charles A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (03): : 258 - 265
  • [10] Bcr-Abl tyrosine kinase inhibitors- current status
    Mughal, Anum
    Aslam, Hafiz Muhammad
    Khan, Aga Muhammad Hammad
    Saleem, Shafaq
    Umah, Ribak
    Saleem, Maria
    INFECTIOUS AGENTS AND CANCER, 2013, 8
12345